CureImmune


Public list: Pharma Startups (4732) Cancer Therapeutics (1137)

CureImmune is developing an immuno-oncology checkpoint inhibitor drug that is a stable small molecule, inexpensive to manufacture, easy to store and ship, and that can be administered at home.

CureImmune is developing an immuno-oncology checkpoint inhibitor drug that is a stable small molecule, inexpensive to manufacture, easy to store and ship, and that can be administered at home.

Company (Alive / Active)

Phone:

Fax:

Fitzsimmons Bioscience Center
12635 E. Montview Blvd. Suite 100G
Aurora, 80045
Colorado, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
CureImmune $0M May 19, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related CureImmune Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Colorado Office of Economic Development and International TradeGovernmentDenver, Colorado, United StatesGrant
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)